Mindfulness Texting for Medication Adherence and Chronic Pain Management (MiMA)
Integrating Mindfulness and mHealth Approaches for Treating Opioid Use Disorder and Chronic Pain
The goal of this clinical trial is to examine the effects of reminder and mindfulness text messages based on integrated Acceptance and Commitment Therapy and Mindfulness Based Relapse Prevention (ACT+MBRP) on medication adherence and managing craving, pain, mindfulness, and withdrawal symptoms in people taking medications for opioid use disorder and with chronic pain through assessment questions collected six times daily during the course of treatment. The main questions it aims to answer are:
- Do daily medication reminder text messages increase medication adherence for people taking medications for opioid use disorder?
- To what extent do people engage with the daily mindfulness messages?
- Do participants receiving a structured curriculum of mindfulness messages delivered twice daily differ from those receiving randomly selected mindfulness messages delivered four times daily in engagement with the intervention?
- How do the two mindfulness text messaging interventions differ in their effects on intervention engagement, craving, pain, mindfulness, and withdrawal symptoms?
Participants will:
- Receive daily medication reminder text messages for 12 weeks (i.e., 3 months)
- Receive either 2 or 4 mindfulness messages per day for 6 weeks
- Answer brief assessment questions six times per day during the 6-week mindfulness text messaging period
- Complete questionnaires at enrollment (baseline), once each week during the 6-week mindfulness text messaging period (6 total), immediately after the 6-week mindfulness text messaging period (post-treatment), and 6 weeks after the mindfulness text messaging period ends (follow-up)
研究概览
详细说明
This study will examine the acceptability, feasibility, and effectiveness of mindfulness text messages for increasing adherence to medication for opioid use disorder and helping participants manage pain, pain interference, craving, withdrawal symptoms, and mindfulness. The study sends either two or four daily mindfulness text messages for six weeks as well as daily medication reminder text messages for 12 weeks. Participants in the two message per day condition receive an identical curriculum of messages developed based on the integrated ACT+MBRP manual (e.g., the same messages in the same order). Message delivery time is randomized to one of six windows throughout the day. Participants in the four message per day condition receive four random messages from our pool of over 200 mindfulness messages (e.g., different messages and order for each participant). Message delivery time is also randomized to one of the same six windows throughout the day as the other condition. Participants are blinded to the differences in conditions. Medication adherence will be assessed using daily self-report throughout the study.
The study will compare the effects of the two mindfulness text messaging interventions on craving, pain, pain interference, mindfulness, and medication adherence. Secondary outcomes include engagement with the mindfulness text messages, state mindfulness, values-based living, substance misuse, and self-efficacy. Sixty participants who are initiating or restarting medication for opioid use disorder (e.g., methadone or buprenorphine) and who have chronic pain will be enrolled. Participants will complete baseline questionnaires before beginning the intervention, brief ecological momentary assessment (EMA) questions six times per day during the 6-week mindfulness text messaging period, weekly questionnaires during the intervention (6 total), a post-treatment assessment at the end of the 6-week mindfulness text messaging period, and a follow-up assessment 6 weeks after the intervention ends. Daily medication reminder text messages will continue throughout the 12-week study period.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名：Frank Schwebel, PhD
- 电话号码：505-456-3014
- 邮箱：textlabresearch@gmail.com
学习地点
-
-
New Mexico
-
Albuquerque、New Mexico、美国、87131
- 招聘中
- University of New Mexico
-
接触：
- Frank Schwebel, PhD
- 电话号码：505-456-3014
- 邮箱：textlabresearch@gmail.com
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Age 18 years or older
- Reside in the United States
- Own or have access to a mobile phone capable of sending and receiving text messages
- Have reliable internet access to complete study surveys
- Be willing and able to comply with all study procedures and remain available for the duration of the study
- Be interested in receiving medication reminders and mindfulness text messages
- Be within 2 months of initiating or restarting methadone or buprenorphine treatment for opioid use
- Report chronic pain (pain lasting at least 3 months)
- Live in the United States
Exclusion Criteria:
- None
学习计划
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Mindfulness curriculum
Participants in this condition receive two mindfulness messages per day at random times as part of a curriculum based on the ACT+MBRP treatment manual.
|
Over 200 text messages based on concepts from Acceptance and Commitment Therapy (ACT) and Mindfulness-Based Relapse Prevention (MBRP) were developed and are sent to participants each day for 6 weeks.
The messages are intended to increase awareness of triggers and "automatic" reactions to triggering experiences, and to consider alternative responses to these experiences.
|
|
实验性的：Random mindfulness messages
Participants in this condition receive four random mindfulness messages per day at random times from the complete bank of mindfulness messages developed based on the Monitoring and Acceptance Theory of mindfulness.
|
Over 200 text messages based on concepts from Acceptance and Commitment Therapy (ACT) and Mindfulness-Based Relapse Prevention (MBRP) were developed and are sent to participants each day for 6 weeks.
The messages are intended to increase awareness of triggers and "automatic" reactions to triggering experiences, and to consider alternative responses to these experiences.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Engagement with mindfulness text messages
大体时间：Measured daily for six weeks
|
Engagement with the mindfulness text messages is assessed using one binary item asking whether participants thought about or used any suggestion from the MiMA Study text messages since that morning and one 11-point rating (0 = not at all to 10 = very much) assessing the extent to which participants thought about or used the suggestions.
Participants also rate the extent to which the mindfulness text messages helped them manage pain, opioid craving, medication adherence, and withdrawal symptoms (0 = not at all to 10 = very much).
|
Measured daily for six weeks
|
|
Intervention acceptability
大体时间：From baseline to 12-week (i.e., 3-month) follow-up
|
Acceptability will be assessed using an adapted message fatigue questionnaire and intervention engagement scale.
Items are rated on 5-point Likert scales, with mean scores greater than 3 indicating acceptable levels of intervention satisfaction.
|
From baseline to 12-week (i.e., 3-month) follow-up
|
|
Intervention feasibility
大体时间：From baseline to 12-week (i.e., 3-month) follow-up
|
Feasibility will be evaluated using recruitment, retention, and survey completion rates.
Prespecified benchmarks include recruitment of at least 50% of eligible participants and retention rates of at least 75%, 65%, and 55% at Weeks 3, 6, and 12, respectively.
Responding to EMA on 25%, 50%, and 75% of days will indicate a low, medium, and high level of feasibility, respectively.
|
From baseline to 12-week (i.e., 3-month) follow-up
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Perceived benefits of mindfulness text messages
大体时间：Measured daily for six weeks
|
Participants indicate how much they believe the mindfulness text messages helped them engage in valued activities, engage in everyday activities, be mindful, and accept thoughts and situations without judgement (response range: 0=not at all, 10=very much).
|
Measured daily for six weeks
|
|
Mindfulness
大体时间：Measured daily for six weeks
|
Mindfulness will be assessed through a 6-item EMA scale that measures state mindfulness in the past 15 minutes.
Responses are made on a 5-point response scale ranging from 1 (not at all) to 5 (very much).
|
Measured daily for six weeks
|
|
Pain Measurement
大体时间：Measured daily for six weeks
|
Pain is assessed using a single-item asking participants to rate their current pain compared to their typical pain level.
Responses are made on a 10-point response scale ranging from 0 (a lot less than usual) to 10 (a lot more than usual).
A response of 5 represents "about the same as usual".
|
Measured daily for six weeks
|
|
Pain interference
大体时间：Measured daily for six weeks
|
Pain interference is assessed using two items assessing interference with what participants are doing and their enjoyment of life.
Responses are made on an 11-point response scale ranging from 0 (not at all) to 10 (very much).
|
Measured daily for six weeks
|
|
Medication adherence
大体时间：From baseline to 12-week (i.e., 3-month) follow-up
|
Medication adherence will be assessed using daily self-report of medication for opioid use disorder (MOUD) use.
Within-participant adherence will be calculated as the percentage of study days on which participants reported taking their medication as prescribed.
Participants taking medication on at least 80% of study days will be classified as adherent.
|
From baseline to 12-week (i.e., 3-month) follow-up
|
|
Craving
大体时间：Measured daily for six weeks
|
Craving is assessed using two items asking participants to rate the strength of their urge and their need to use opioids on an 11-point response scale ranging from 0 (not at all) to 10 (very much).
|
Measured daily for six weeks
|
|
Self-efficacy
大体时间：Measured daily for six weeks
|
Self-efficacy is assessed using a single item asking participants to rate their confidence in their ability to not use opioids on an 11-point response scale ranging from 0 (not at all) to 10 (very much).
|
Measured daily for six weeks
|
|
Values
大体时间：Measured daily for six weeks
|
Values-based living is assessed using two items adapted from the Values Tracker for ecological momentary assessment (EMA).
The items measure engagement in actions that contribute to participants' quality of life and progress toward life areas that are important to them.
Responses are made on an 11-point scale ranging from 0 (not at all) to 10 (extremely).
|
Measured daily for six weeks
|
|
Opioid misuse
大体时间：Measured daily for six weeks
|
Opioid misuse is assessed using a single item asking participants to endorse whether or not they have used non-prescription or prescription opioids more frequently than prescribed since they last completed a survey.
|
Measured daily for six weeks
|
|
Withdrawal symptoms
大体时间：Measured daily for six weeks
|
Withdrawal symptoms are assessed using one binary item asking whether participants experienced opioid withdrawal symptoms since the previous assessment and one 11-point rating assessing current withdrawal severity (0 = not at all to 10 = very much).
|
Measured daily for six weeks
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.